200th Treatment Milestone for AIRFLOW-3 COPD Trial

/PRNewswire/ -- Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, announces two treatment milestones. 200 patients have...

Related Keywords

United States ,Brompton ,Medway ,United Kingdom ,London ,City Of ,Pallav Shah ,Prnewswire Nuvaira ,Gerard Criner ,Professor Of Respiratory Medicine At Imperial College ,Nuvaira Inc ,Innovatus Capital Partners ,Treated Worldwide ,Targeted Lung Denervation ,Thoracic Medicine ,Lewis Katz School ,Temple University ,Consultant Physician ,Royal Brompton Hospitals ,Respiratory Medicine ,Imperial College ,Targeted Lung Denervation System ,Nuvaira ,